Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
National Cancer Institute (NCI)
National Comprehensive Cancer Network
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT01413113
First received: July 20, 2011
Last updated: November 4, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)